National

FBI's Patel faces US congressional hearings after Kirk death probe missteps

Sep 15, 2025

New York [US], September 15: FBI Director Kash Patel is bracing for United States congressional scrutiny over his leadership of the investigation into the killing of conservative commentator Charlie Kirk, following early reported missteps, including his erroneous announcement on social media that "the subject" in the killing was in custody.
Patel is set to appear on Tuesday and Wednesday before the Senate and House judiciary committees, during which he is expected to answer questions not just about how the FBI handled the Kirk case, but also whether he can stabilise an agency fragmented by political fights and internal upheaval since his appointment, as toxic political divisions plague the nation.
US President Donald Trump praised Patel on Saturday for the speed with which the bureau identified and captured Kirk's alleged assassin, Tyler Robinson. But that has not stopped criticism even from fellow conservatives, who have started to wonder if Patel is qualified to head the country's top law enforcement body of 38,000 employees, including 13,000 agents. In a statement posted on X on Friday, Christopher F Rufo, a fellow at the conservative think tank Manhattan Institute, wrote that it was "time for Republicans to assess whether Kash Patel is the right man to run the FBI".
"He performed terribly in the last few days, and it's not clear whether he has the operational expertise to investigate, infiltrate, and disrupt the violent movements - of whatever ideology - that threaten the peace in the United States," he added.
"I've been on the phone the last few days with many conservative leaders, all of whom wholeheartedly support the Trump Administration and none of whom are confident that the current structure of the FBI is up to this task," Rufo further said. (Agencies)
Source: Qatar Tribune

More news

Kapiva Partners with Central Council for Research in Ayurvedic Sciences (CCRAS) to Commercialise Clinically Evaluated Ayurvedic Formulations

New Delhi [India], September 17: Kapiva, one of India’s most trusted science-backed Ayurvedic brands, has entered into a strategic technology transfer and commercialisation alliance with the Central Council of Research in Ayurvedic Sciences (CCRAS), an apex research body under the Ministry of AYUSH, Government of India, to bring clinically evaluated Ayurvedic technologies and formulations to a wider consumer base.

Sep 17, 2026